Metabolomics: An essential tool to understand the function of peroxisome proliferator-activated receptor alpha

Toxicologic Pathology

Volumn 41, Issue 2, 2013, Pages 410-418

  Montanez, Jessica E ^a   Peters, Jeffrey M ^a   Correll, Jared B ^a   Gonzalez, Frank J ^b   Patterson, Andrew D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

chromatography; liver; mass spectrometry; metabolomics; PPAR

Indexed keywords

1 METHYLNICOTINAMIDE; ACETYLCARNITINE; ATROLACTIC ACID; CLOFIBRATE; CYTOCHROME P450 2E1; FENOFIBRATE; GLUCOSE; METHYLGUANIDINE; N ACETYL 1,4 BENZOQUINONE IMINE; NICOTINAMIDE; PANTOTHENIC ACID; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; QUINOLINIC ACID; TRIACYLGLYCEROL;

BIOINFORMATICS; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; DRUG CYTOTOXICITY; DRUG URINE LEVEL; ELECTROSPRAY; ENERGY METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCONEOGENESIS; HUMAN; LIVER TOXICITY; METABOLOMICS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SYSTEMATIC REVIEW; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TOXIC HEPATITIS; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; CHROMATOGRAPHY; DRUG-INDUCED LIVER INJURY; HUMANS; MASS SPECTROMETRY; METABOLOMICS; PPAR ALPHA; TOXICOLOGY;

EID: 84875733856     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312466960     Document Type: Review

References (51)

1. Akiyama T. E., Nicol C. J., Fievet C., Staels B., Ward J. M., Auwerx J., Lee S. S., Gonzalez F. J., Peters J. M.. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: Studies with congenic mouse lines. J Biol Chem. 2001 ; 276: 39088-93
2. Atherton H. J., Bailey N. J., Zhang W., Taylor J., Major H., Shockcor J., Clarke K., Griffin J. L.. A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics. 2006 ; 27: 178-86
3. Atherton H. J., Gulston M. K., Bailey N. J., Cheng K. K., Zhang W., Clarke K., Griffin J. L.. Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol Syst Biol. 2009 ; 5: 259
4. Bility M. T., Thompson J. T., McKee R. H., David R. M., Butala J. H., Vanden Heuvel J. P., Peters J. M.. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol Sci. 2004 ; 82: 170-82
5. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W.. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996 ; 137: 354-66
6. Chen C., Krausz K. W., Shah Y. M., Idle J. R., Gonzalez F. J.. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol. 2009 ; 22: 699-707
7. Cottingham K.. HUSERMET researchers look to the metabolome for answers. J Proteome Res. 2008 ; 7: 4213
8. D'Arcy P. F.. Paracetamol. Adverse Drug React Toxicol Rev. 1997 ; 16: 9-14
9. Daviss B.. Growing pains for metabolomics. Scientist. 2005 ; 19: 25-28
10. Desvergne B., Michalik L., Wahli W.. Transcriptional regulation of metabolism. Physiol Rev. 2006 ; 86: 465-514
11. Dettmer K., Aronov P. A., Hammock B. D.. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007 ; 26: 51-78
12. Eliasson M., Rannar S., Madsen R., Donten M. A., Marsden-Edwards E., Moritz T., Shockcor J. P., Johansson E., Trygg J.. Strategy for optimizing LC-MS data processing in metabolomics: A design of experiments approach. Anal Chem. 2012 ; 84: 6869-76
13. Francis G. A., Fayard E., Picard F., Auwerx J.. Nuclear receptors and the control of metabolism. Ann Rev Physiol. 2003 ; 65: 261-311
14. Fruchart J. C., Duriez P., Staels B.. [Molecular mechanism of action of the fibrates]. J Societe De Biologie. 1999 ; 193: 67-75
15. Gonzalez F. J.. The 2006 Bernard B. Brodie award lecture. Cyp2e1. Drug Metabol Dispos. 2007 ; 35: 1-8
16. Gonzalez F. J., Peters J. M., Cattley R. C.. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst. 1998 ; 90: 1702-709
17. Griffin J. L., Nicholls A. W.. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics. 2006 ; 7: 1095-107
18. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J. M., Winegar D. A., Willson T. M., Fruchart J. C., Berge R. K., Staels B.. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem. 2000 ; 275: 16638-642
19. Idle J. R., Gonzalez F. J.. Metabolomics. Cell Metabol. 2007 ; 6: 348-51
20. Issemann I., Green S.. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990 ; 347: 645-50
21. Johnson C. H., Patterson A. D., Idle J. R., Gonzalez F. J.. Xenobiotic metabolomics: Major impact on the metabolome. Ann Rev Pharmacol Toxicol. 2012 ; 52: 37-56
22. Katajamaa M., Miettinen J., Oresic M.. MZmine: Toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics. 2006 ; 22: 634-36
23. Kim Y. G., Lou A. C., Saghatelian A.. A metabolomics strategy for detecting protein-metabolite interactions to identify natural nuclear receptor ligands. Mol Biosys. 2011 ; 7: 1046-49
24. Lee S. S., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J.. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995 ; 15: 3012-22
25. Manna S. K., Patterson A. D., Yang Q., Krausz K. W., Idle J. R., Fornace A. J., Gonzalez F. J.. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res. 2011 ; 10: 4120-33
26. Manna S. K., Patterson A. D., Yang Q., Krausz K. W., Li H., Idle J. R., Fornace A. J., Gonzalez F. J.. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res. 2010 ; 9: 4176-88
27. Mazer M., Perrone J.. Acetaminophen-induced nephrotoxicity: Pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008 ; 4: 2-6
28. Ohta T., Masutomi N., Tsutsui N., Sakairi T., Mitchell M., Milburn M. V., Ryals J. A., Beebe K. D., Guo L.. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol. 2009 ; 37: 521-35
29. Patterson A. D., Gonzalez F. J., Idle J. R.. Xenobiotic metabolism: A view through the metabolometer. Chem Res Toxicol. 2010 ; 23: 851-60
30. Patterson A. D., Idle J. R. Ballantyne B., ed. John Wiley and Sons, West Sussex, UK ; 2009 :
31. Patterson A. D., Lanz C., Gonzalez F. J., Idle J. R.. The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev. 2010 ; 29: 503-21
32. Patterson A. D., Peters J. M.. PPAR action in insulin resistance unraveled by metabolomics: Potential clinical implications. Genome Med. 2011 ; 3: 54
33. Patterson A. D., Shah Y. M., Matsubara T., Krausz K. W., Gonzalez F. J.. PPARalpha-dependent induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology. 2012 ; 56 :
34. Patterson A. D., Slanar O., Krausz K. W., Li F., Hofer C. C., Perlik F., Gonzalez F. J., Idle J. R.. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation. J Proteome Res. 2009 ; 8: 4293-300
35. Patti G. J., Shriver L. P., Wassif C. A., Woo H. K., Uritboonthai W., Apon J., Manchester M., Porter F. D., Siuzdak G.. Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome. Neuroscience. 2010 ; 170: 858-64
36. Patti G. J., Woo H. K., Yanes O., Shriver L., Thomas D., Uritboonthai W., Apon J. V., Steenwyk R., Manchester M., Siuzdak G.. Detection of carbohydrates and steroids by cation-enhanced nanostructure-initiator mass spectrometry (NIMS) for biofluid analysis and tissue imaging. Anal Chem. 2010 ; 82: 121-28
37. Pearson H.. Meet the human metabolome. Nature. 2007 ; 446: 8
38. Peters J. M., Shah Y. M., Gonzalez F. J.. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Canc. 2012 ; 12: 181-95
39. Pluskal T., Castillo S., Villar-Briones A., Oresic M.. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010 ; 11: 395
40. Roberts L. D., Murray A. J., Menassa D., Ashmore T., Nicholls A. W., Griffin J. L.. The contrasting roles of PPARdelta and PPARgamma in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol. 2011 ; 12: R75
41. Shin M., Kim I., Inoue Y., Kimura S., Gonzalez F.J.. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha. Mol Pharmacol. 2006 ; 70: 1281-90
42. Smith C. A., Want E. J., O'Maille G., Abagyan R., Siuzdak G.. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006 ; 78: 779-87
43. Tautenhahn R., Patti G. J., Rinehart D., Siuzdak G.. XCMS Online: A web-based platform to process untargeted metabolomic data. Anal Chem. 2012 ; 84: 5035-39
44. van Doorn M., Vogels J., Tas A., van Hoogdalem E. J., Burggraaf J., Cohen A., van der Greef J.. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol. 2007 ; 63: 562-74
45. Wang T., Shah Y. M., Matsubara T., Zhen Y., Tanabe T., Nagano T., Fotso S., Krausz K. W., Zabriskie T. M., Idle J. R., Gonzalez F. J.. Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis. J Biol Chem. 2010 ; 285: 7670-85
46. Watkins S. M., Reifsnyder P. R., Pan H. J., German J. B., Leiter E. H.. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res. 2002 ; 43: 1809-17
47. Wishart D. S., Tzur D., Knox C., Eisner R., Guo A. C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M. A., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D. D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G. E., Macinnis G. D., Weljie A. M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B. D., Vogel H. J., Querengesser L.. HMDB: The Human Metabolome Database. Nucleic Acids Res. 2007 ; 35: D521-26
48. Woo H. K., Northen T. R., Yanes O., Siuzdak G.. Nanostructure-initiator mass spectrometry: A protocol for preparing and applying NIMS surfaces for high-sensitivity mass analysis. Nat Protoc. 2008 ; 3: 1341-49
49. Xu J., Xiao G., Trujillo C., Chang V., Blanco L., Joseph S. B., Bassilian S., Saad M. F., Tontonoz P., Lee W. N., Kurland I. J.. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem. 2002 ; 277: 50237-44
50. Yang Q., Nagano T., Shah Y., Cheung C., Ito S., Gonzalez F. J.. The PPAR alpha-humanized mouse: A model to investigate species differences in liver toxicity mediated by PPAR alpha. Toxicol Sci. 2008 ; 101: 132-39
51. Zhen Y., Krausz K. W., Chen C., Idle J. R., Gonzalez F. J.. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol Endocrinol. 2007 ; 21: 2136-51